Major support zones hit on the fib lines, with obvious resistance levels that are ready to break. Initial had broken down, potential support highlighted with lower purple line. Pinch is inevitable.
Q4 earning should be released early March. Expecting the recognition of their $2.8mil contract, in addition to their typical $1.5mil recognized from smaller contracts.
Surge in on positive and continuation of the favorable cannabis landscape (feds and states), can push this to retest their recent high around .21.
If SRNA breaks that on good , then it is blue skies.